These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3887313)

  • 21. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
    Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
    Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A preliminary study on pharmacokinetics of oral indomethacin in premature infants in north India.
    Sharma PK; Garg SK; Narang A
    Indian J Med Res; 2003 Apr; 117():164-9. PubMed ID: 14604305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams.
    Supapannachart S; Khowsathit P; Patchakapati B
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S87-92. PubMed ID: 10730525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
    Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for persistent ductus arteriosus patency during indomethacin treatment.
    Chorne N; Jegatheesan P; Lin E; Shi R; Clyman RI
    J Pediatr; 2007 Dec; 151(6):629-34. PubMed ID: 18035143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized trial of sterile water by gavage drip in the fluid management of extremely low birth weight infants.
    Stewart CD; Morris BH; Huseby V; Kennedy KA; Moya FR
    J Perinatol; 2009 Jan; 29(1):26-32. PubMed ID: 18754014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of oral and intravenous indomethacin in preterm infants.
    Bhat R; Vidyasagar D; Fisher E; Hastreiter A; Ramirez JL; Burns L; Evans M
    Dev Pharmacol Ther; 1980; 1(2-3):101-10. PubMed ID: 6927543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous indomethacin and changes of renal function in premature infants with patent ductus arteriosus.
    John EG; Vasan U; Hastreiter AR; Bhat R; Evans MA
    Pediatr Pharmacol (New York); 1984; 4(1):11-9. PubMed ID: 6739182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does indomethacin affect the control of breathing in premature infants?
    Yeh TF; Wilks A
    Dev Pharmacol Ther; 1989; 12(4):211-6. PubMed ID: 2766924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
    Cordero L; Nankervis CA; Gardner D; Giannone PJ
    J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preliminary report--heparin counteracts indomethacin effect on ductus arteriosus in very low birthweight infants.
    Ojala TH; Lehtonen L
    Pediatr Crit Care Med; 2007 May; 8(3):258-60. PubMed ID: 17496511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus.
    Yeh TF; Raval D; Lilien LD; Srinivasan G; Pildes RS
    Pediatr Pharmacol (New York); 1982; 2(3):171-7. PubMed ID: 6761637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indomethacin treatment in patent ductus arteriosus. A double-blind study utilizing indomethacin plasma levels.
    Nestrud RM; Hill DE; Arrington RW; Beard AG; Dungan WT; Lau PY; Norton JB; Readinger RI
    Dev Pharmacol Ther; 1980; 1(2-3):125-36. PubMed ID: 6765467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus.
    Van Overmeire B; Touw D; Schepens PJ; Kearns GL; van den Anker JN
    Clin Pharmacol Ther; 2001 Oct; 70(4):336-43. PubMed ID: 11673749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indomethacin therapy for large patent ductus arteriosus in the very low birth weight infant: results and complications.
    Halliday HL; Hirata T; Brady JP
    Pediatrics; 1979 Aug; 64(2):154-9. PubMed ID: 471605
    [No Abstract]   [Full Text] [Related]  

  • 39. Does indomethacin cause extension of intracranial hemorrhages: a preliminary study.
    Maher P; Lane B; Ballard R; Piecuch R; Clyman RI
    Pediatrics; 1985 Mar; 75(3):497-500. PubMed ID: 3883305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Indomethacin in the treatment of patent ductus arteriosus in premature newborn infants].
    Ventura-Juncá P; González A; Arrizaga N
    Rev Chil Pediatr; 1991; 62(5):293-7. PubMed ID: 1844937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.